*This content was translated by AI.
KGC Ginseng Corporation's Jung Kwan Jang GLPro has announced its global expansion drive.
Jung Kwan Jang's blood sugar specialty brand 'GLPro (GLPro)' has surpassed cumulative sales of 20 billion won in the domestic market. Jung Kwan Jang is not stopping here but is now planning a broader vision. Having confirmed growth potential in overseas markets such as Malaysia, it is accelerating its efforts to penetrate the global market.
The key ingredient of GLPro, 'KGC05pg', is an individually recognized raw material extracted from Jung Kwan Jang red ginseng. Through a 12-week human application trial, it demonstrated significant improvement effects on six blood sugar indicators: fasting blood glucose, postprandial blood glucose, glycated hemoglobin, and GLP-1, among others, earning functional recognition from the Ministry of Food and Drug Safety.
GLPro sold 3,100 sets within five days of its domestic launch and reached 10,000 sets within 15 days, surpassing cumulative sales of 20 billion won after launch to establish itself as Jung Kwan Jang's next-generation brand. Building on this achievement, the company is expanding its global reach through products and marketing strategies tailored to overseas demand.
Notably, it is achieving meaningful results in the Malaysian market. After launching 'GLPro Core' in Malaysia earlier this year, the initial shipment sold out completely, and recent monthly export performance has shown growth trends, with increases of up to 90% compared to the previous month.
Based on its success in the Malaysian market, Jung Kwan Jang plans to expand its customer base into the local Muslim market. Moving beyond the existing Chinese community market, the company is pursuing Halal certification to target Malaysia's major consumer segment—the Muslim population—and intends to introduce dedicated products for Muslim consumers in the future.
In a phone interview with this newspaper, a KGC Ginseng Corporation official stated, "GLPro has proven its growth potential as a next-generation brand by surpassing cumulative sales of 20 billion won domestically. Going forward, we plan to enhance GLPro's competitiveness in the global blood sugar management market through market-specific strategies that reflect consumer characteristics and health concerns in each country."
<© STARNEWS. All rights reserved. No reproduction or redistribution allowed.>
*This content was translated by AI.
